Pamidronate therapy for hypercalcemia and congenital mesoblastic nephroma: a case report
Open Access
- 12 December 2009
- journal article
- Published by Springer Nature in Cases Journal
- Vol. 2 (1) , 9315
Abstract
Hypercalcemia can causes life threatening complications. We report an infant with severe hypercalcemia due to congenital mesoblastic nephroma. Hypercalcemia was corrected before nephrectomy by pamidronate. According to our knowledge this is a rare case with severe neoplasm induced hypercalcemia among neonates who treated by bisphosphonates. The aim of this report is to define new approach to neoplasm induced neonatal hypercalcemia.Keywords
This publication has 9 references indexed in Scilit:
- Neonatal Hyperparathyroidism and Pamidronate Therapy in an Extremely Premature InfantPediatrics, 2007
- Pamidronate: Treatment for Severe Hypercalcemia in Neonatal Subcutaneous Fat NecrosisHormone Research in Paediatrics, 2006
- Pamidronate Treatment for Hypercalcemia in an Infant Receiving Parenteral NutritionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- Renal tumors in infants less than 6 months of ageJournal of Pediatric Surgery, 2004
- Congenital mesoblastic nephroma associated with polyhydramnios and hypercalcemiaPediatric Nephrology, 2002
- Polyhydramnios and hypercalcemia associated with congenital mesoblastic nephroma: Case report and a new appraisalObstetrics & Gynecology, 1995
- PTH mRNA transcription analysis in infantile tumors associated with hypercalcemiaCancer, 1988
- Hypercalcemia in childhood renal tumorsCancer, 1988
- Ectopic G-29 and G-37 glucagon secretion by hypercalcemic infantile renal tumorsPeptides, 1986